Sanofi India Ltd.
Snapshot View

View in App

Prices View details >>

5900.00 -85.35 ▼-1.4%

06 October 2022, 04:01:00 PM
Volume: 1,544

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sanofiindialtd.com
Market Cap 13,565.50 Cr.
Enterprise Value(EV) 12,889.07 Cr. 2022-06
Financial Indicators
Earnings per share (EPS) 425.09 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 13.86 Trailing Twelve Months Ending 2022-06
Industry PE 32.07 Trailing Twelve Months Ending 2022-06
Book Value / Share 631.65 Trailing Twelve Months Ending 2022-06
Price to Book Value 9.33 Calculated using Price: 5,890.20
Dividend Yield 8.32 Period Ending 2021-12
No. of Shares Subscribed 2.30 Cr. 23,030,622 Shares
FaceValue 10
Company Profile
The company is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. The company prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. The company stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.43%
1 Week
+1.82%
1 Month
-4.03%
3 Month
-9.03%
6 Month
-24.36%
1 Year
-25.37%
2 Year
-32.45%
5 Year
+45.00%
10 Year
+159.91%

Ratios View Details >>

9 years 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 2020-12 2021-12
Return on Equity (%) 20.97 18.70 20.68 17.43 16.87 18.18 18.07 21.39 44.65
Return on Capital Employed (%) 30.75 26.47 30.96 27.51 26.38 28.76 25.75 29.77 57.98
Return on Assets (%) 15.11 12.84 13.88 12.30 9.50 8.37 8.28 9.24 17.74

Balance Sheet View Details >>

Particulars 10 years 2013-12 Rs. Cr. 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2019-12 Rs. Cr. 2020-12 Rs. Cr. 2021-12 Rs. Cr. 2022-06* Rs. Cr.
Shh. Funds 1,347 1,486 1,627 1,883 2,026 2,219 2,442 2,119 2,226 1,455
Non Curr. Liab. 63 86 161 156 1,335 1,357 1,124 1,280 1,039 72
Curr. Liab. 469 656 617 502 962 1,193 1,674 1,694 2,291 650
Minority Int.
Equity & Liab. 1,878 2,228 2,405 2,541 4,324 4,769 5,240 5,093 5,555 2,177
Non Curr. Assets 931 965 1,161 966 2,519 2,608 2,141 2,253 1,876 466
Curr. Assets 947 1,263 1,244 1,575 1,805 2,162 3,099 2,841 3,679 1,710
Misc. Exp. not W/O
Total Assets 1,878 2,228 2,405 2,541 4,324 4,769 5,240 5,093 5,555 2,177

Profit Loss View Details >>

Particulars 10 years 2013-12 Rs. Cr. 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2019-12 Rs. Cr. 2020-12 Rs. Cr. 2021-12 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 1,809 1,977 2,193 2,367 2,464 2,771 3,071 2,902 2,957 2,849
Other Income 58 64 51 66 81 90 94 90 75 71
Total Income 1,867 2,042 2,245 2,433 2,544 2,861 3,165 2,992 3,031 2,920
Total Expenditure -1,411 -1,639 -1,734 -1,832 -1,926 -2,148 -2,405 -2,189 -2,194 -2,167
PBIDT 456 403 511 602 618 713 759 803 837 753
Interest 0 0 0 -2 -1 -1 0 -2 -2 -2
Depreciation -92 -97 -113 -119 -102 -103 -100 -82 -67 -47
Taxation -123 -109 -159 -176 -189 -229 -186 -200 -313 -333
Exceptional Items 25 67 84 -59 -42 489 607
PAT 265 264 322 304 326 381 414 478 944 979
Adjusted EPS 115 114 140 132 142 165 180 208 411 426

Cash Flow View Details >>

Particulars 10 years 2012-12 Rs. Cr. 2013-12 Rs. Cr. 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2019-12 Rs. Cr. 2020-12 Rs. Cr. 2021-12 Rs. Cr.
Cash Fr. Operatn. 290 273 265 213 322 435 374 412 611 559
Cash Fr. Inv. -5 -335 61 36 -155 -79 -73 66 276 631
Cash Fr. Finan. -90 -105 -122 -147 -180 -188 -197 -183 -810 -849
Net Change 195 -168 205 102 -13 168 104 295 78 341
Cash & Cash Eqvt 429 261 466 568 554 722 825 1,120 1,197 1,538

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 60.40 60.40 60.40 60.40 60.40 60.40 60.40 60.40 60.40
Public 39.60 39.60 39.60 39.60 39.60 39.60 39.60 39.60 39.60
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 06 Oct 2022
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Link Intime India Private Limited Registrar and Share Transfer Agent (RTA) of the Company has provided the enclosed certificate for the quarter ended 30th September 2022 under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018.
Thu, 06 Oct 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate
Thu, 06 Oct 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Revised: Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate

Technical Scans View Details >>

Tue, 04 Oct 2022
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 6 Months High Decrease 6 Months
Closing Near 20 SMA Closing Near 20 SMA
Close Crossing 20 SMA From Below Close Crossing 20 SMA From Below
CCI Trending Up CCI Trending Up

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,896.56 954.00 +1.2%
Divi's Laboratories Ltd. 99,171.10 3,735.70 -1.2%
Cipla Ltd. 91,534.16 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. 73,236.99 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. 63,161.01 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. 54,354.34 1,606.00 +0.9%
Zydus Lifesciences Ltd. 42,831.42 423.15 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.85 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 31.94 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-06 36.78 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.49 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.49 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 67.86 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.69 423.15 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.57 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-06 4.26 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.62 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.50 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.55 423.15 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 423.15 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 423.15 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 423.15 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 423.15 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 423.15 +0.8%

FAQ's On Sanofi India Ltd.

What is Sanofi India share price?
Can I buy Sanofi India shares now?
What is the Dividend Yield of Sanofi India?
What is the Market Cap of Sanofi India?
What are the key metrics to analyse Sanofi India?
What is the 52 Week High and Low of Sanofi India?
What is the trend of Sanofi India share price?